Tom Fraites

As both a scientist and engineer, Tom has spent his entire career at the intersection of technologies and healthcare applications. As part of his graduate training at the University of Florida Powell Gene Therapy Center, Tom published some of the first demonstrations of correction of a musculoskeletal disorder using recombinant viral gene therapy vectors and also contributed key data demonstrating the preclinical efficacy of an enzyme replacement therapy. During that time, he also completed a joint program in business and biotechnology, which planted the seeds for a career in the biomedical industry.

Beginning with his postdoctoral fellowship, Tom led numerous technology development programs in cell therapy, regenerative medicine, and enabling technologies at BD Technologies (Becton Dickinson) in North Carolina.